Alto Neuroscience Inc.
ANRO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.01B
Close$
$5.96
79.6% downside
Current Fair Value
79.6% downsideOvervalued by 79.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.01 Billion |
|---|---|
| Enterprise Value | $748.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.19 |
| Beta | 1.07 |
| Outstanding Shares | 32,893,000 |
Return
| Return on Equity | -30.53% |
|---|---|
| Return on Assets | -26.90% |
| Return on Invested Capital | -29.04% |
Valuation & Multiples
| P/E Ratio | -11.56 |
|---|---|
| PEG | -15.84 |
| Price to Sales | - |
| Price to Book Ratio | 4.17 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -9.79 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.73
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 19, 2026
EPS Estimate
$-0.62
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0339▲ 3.39% |
|---|---|
| Total Calls | 462,500▲ 4.28% |
| Total Puts | 15,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.99%▲ 7.39% |
|---|---|
| Total Invested | $602.48M▲ 34.91% |
| Investors Holding | 114▲ 13.00% |
ESG Score
No data